Condition
Persistent Pregnancy of Unknown Location
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
3 treatments under study, led by Methotrexate
Research Leaders
8 sponsors active, led by University of Pennsylvania
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
2Total
Phase 1/2 (1)
Phase 3 (1)
Trial Status
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Methotrexate2
- Uterine Evacuation2
- Expectant Management2
Active Sponsors
- University of Pennsylvania2
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
- University of California, San Francisco1
- Penn State University1
- University of Oklahoma1
Top Investigators
Augusta University
University of Oklahoma
University of Pennsylvania
University of California, San Francisco
University of Pennsylvania
Related Conditions
- Ectopic Pregnancy2